SV2003000849A - HISTAMINE RECEIVER ANTAGONISTS REF.PCS10963AKSR / BB - Google Patents

HISTAMINE RECEIVER ANTAGONISTS REF.PCS10963AKSR / BB

Info

Publication number
SV2003000849A
SV2003000849A SV2002000849A SV2002000849A SV2003000849A SV 2003000849 A SV2003000849 A SV 2003000849A SV 2002000849 A SV2002000849 A SV 2002000849A SV 2002000849 A SV2002000849 A SV 2002000849A SV 2003000849 A SV2003000849 A SV 2003000849A
Authority
SV
El Salvador
Prior art keywords
histamine
ref
receiver
receiver antagonists
histamine receiver
Prior art date
Application number
SV2002000849A
Other languages
Spanish (es)
Inventor
Stephen Jenkinson
Mark Anthony O'reilly
Michael Andrew Trevethick
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of SV2003000849A publication Critical patent/SV2003000849A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/02Nasal agents, e.g. decongestants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/06Antiasthmatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/16Otologicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents

Abstract

PROPORCIONA UNA COMBINACION DE (a) UN ANTAGONISTA DE RECEPTOR H1 DE HISTAMINA Y (b) UN ANTAGONISTA QUE ES AL MENOS 10 VECES MAS SELECTIVO PARA EL RECEPTOR H4 DE HISTAMINA EN COMPARACION CON EL RECEPTOR H3 DE HISTAMINA; Y UN ANTAGONISTA QUE ES AL MENOS 10 VECES MAS SELECTIVO PARA EL RECEPTOR H4 DE HISTAMINA EN COMPARACION CON EL RECEPTOR H3 DE HISTAMINA; Y SUS COMPOSICIONES Y USOS.PROVIDES A COMBINATION OF (a) A HISTAMINE H1 RECEIVER ANTAGONIST AND (b) AN ANTAGONIST THAT IS AT LEAST 10 TIMES MORE SELECTIVE FOR HISTAMINE H4 RECEIVER COMPARED TO HISTAMINE H3 RECEIVER; AND AN ANTAGONIST THAT IS AT LEAST 10 TIMES MORE SELECTIVE FOR H4 HISTAMINE RECEIVER COMPARED TO HISTAMINE RECEIVER H3; AND ITS COMPOSITIONS AND USES.

SV2002000849A 2001-01-17 2002-01-16 HISTAMINE RECEIVER ANTAGONISTS REF.PCS10963AKSR / BB SV2003000849A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0101223.6A GB0101223D0 (en) 2001-01-17 2001-01-17 Histamine receptor antagonists

Publications (1)

Publication Number Publication Date
SV2003000849A true SV2003000849A (en) 2003-01-13

Family

ID=9906993

Family Applications (1)

Application Number Title Priority Date Filing Date
SV2002000849A SV2003000849A (en) 2001-01-17 2002-01-16 HISTAMINE RECEIVER ANTAGONISTS REF.PCS10963AKSR / BB

Country Status (31)

Country Link
EP (1) EP1353657A1 (en)
JP (1) JP2004517883A (en)
KR (1) KR20030069216A (en)
CN (1) CN1486178A (en)
AP (1) AP2002002401A0 (en)
AR (1) AR032101A1 (en)
BG (1) BG107834A (en)
BR (1) BR0206502A (en)
CA (1) CA2435121A1 (en)
CR (1) CR6983A (en)
CZ (1) CZ20031853A3 (en)
DO (1) DOP2002000325A (en)
EA (1) EA200300537A1 (en)
EC (1) ECSP034692A (en)
EE (1) EE200300335A (en)
GB (1) GB0101223D0 (en)
GT (1) GT200200003A (en)
HU (1) HUP0302767A2 (en)
IL (1) IL156087A0 (en)
IS (1) IS6818A (en)
MA (1) MA26980A1 (en)
MX (1) MXPA03006408A (en)
NO (1) NO20033223L (en)
OA (1) OA12440A (en)
PA (1) PA8537101A1 (en)
PL (1) PL362793A1 (en)
SK (1) SK8572003A3 (en)
SV (1) SV2003000849A (en)
TN (1) TNSN02003A1 (en)
WO (1) WO2002056871A2 (en)
ZA (1) ZA200304180B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030133931A1 (en) * 2001-12-21 2003-07-17 Robin Thurmond Use of histamine H4 receptor antagonist for the treatment of inflammatory responses
CA2497788A1 (en) * 2002-09-06 2004-03-18 Janssen Pharmaceutica, N.V. Use of histamine h4 receptor modulators for the treatment of allergy and asthma
WO2004066960A2 (en) * 2003-01-28 2004-08-12 Schering Corporation Combination of h1, h3 and h4 receptor antagonists for treatment of allergic and non-allergic pulmonary inflammation, congestion and allergic rhinitis
US8236786B2 (en) 2008-08-07 2012-08-07 Pulmagen Therapeutics (Inflammation) Limited Respiratory disease treatment
WO2013151982A1 (en) 2012-04-03 2013-10-10 Arena Pharmaceuticals, Inc. Methods and compounds useful in treating pruritus, and methods for identifying such compounds
EP2858647B1 (en) 2012-06-08 2018-05-23 Sensorion H4 receptor inhibitors for treating tinnitus

Also Published As

Publication number Publication date
SK8572003A3 (en) 2004-07-07
EP1353657A1 (en) 2003-10-22
DOP2002000325A (en) 2003-01-31
MXPA03006408A (en) 2003-10-15
KR20030069216A (en) 2003-08-25
MA26980A1 (en) 2004-12-20
CR6983A (en) 2003-11-25
PA8537101A1 (en) 2002-08-29
ZA200304180B (en) 2004-06-15
IL156087A0 (en) 2003-12-23
JP2004517883A (en) 2004-06-17
IS6818A (en) 2003-05-15
GB0101223D0 (en) 2001-02-28
AP2002002401A0 (en) 2002-03-31
AR032101A1 (en) 2003-10-22
GT200200003A (en) 2002-08-19
PL362793A1 (en) 2004-11-02
NO20033223D0 (en) 2003-07-16
NO20033223L (en) 2003-07-16
CN1486178A (en) 2004-03-31
BR0206502A (en) 2003-10-21
CZ20031853A3 (en) 2004-07-14
WO2002056871A2 (en) 2002-07-25
EA200300537A1 (en) 2004-02-26
ECSP034692A (en) 2003-08-29
BG107834A (en) 2004-01-30
EE200300335A (en) 2003-12-15
CA2435121A1 (en) 2002-07-25
TNSN02003A1 (en) 2005-12-23
HUP0302767A2 (en) 2003-11-28
OA12440A (en) 2006-05-22

Similar Documents

Publication Publication Date Title
DE60108420D1 (en) Morpholinderivate als antagonisten an orexinrezeptoren
NO20032253L (en) Piperazinylpyrazine Compounds as Antagonists of Serotonin 5-HT2 Receptors
EA199900630A1 (en) ANTAGONISTS OF VITRONECTIN RECEPTORS
DE60222396D1 (en) N- (2-ARYLETHYL) BENZYLAMINE AS 5-HT6 RECEPTOR ANTAGONIST
HN1998000157A (en) PROSTAGLANDIN AGONISTS
IL155236A0 (en) Association of the cb1 receptor antagonist and a sibutramin, pharmaceutical compositions containing same and use thereof for treating obesity
DK1023074T3 (en) Methods for treating psychosis associated with glucocorticoid-related dysfunction
BR0206595A (en) Compound, pharmaceutical composition, and use of a compound
DK0856001T3 (en) Pyrimidine derivatives as 5-HT 2C receptor antagonists
EA199800140A1 (en) Paroxetine controlled release compositions
DK0975327T3 (en) Use of 5HT3 antagonists to promote intestinal lavage
UY24569A1 (en) BENZOXAZINONE DOPAMINE D4 RECEPTOR ANTAGONISTS
SV2003000849A (en) HISTAMINE RECEIVER ANTAGONISTS REF.PCS10963AKSR / BB
UY26601A1 (en) IL-8 RECEPTOR ANTAGONISTS
ECSP034531A (en) SUBSTITUTED DERIVATIVES OF C-CICLOHEXILMETILAMINA
DK1313485T3 (en) Use of an aldosterone receptor antagonist to improve cognitive function
BR0015980A (en) Agent for prophylaxis or treatment of glaucoma, and, use of an angiotensin ii antagonist
MX9300602A (en) BOMBESIN PHENYLALANINE ANALOGS.
PE20020557A1 (en) USE OF SELECTIVE DOPAMINE D4 RECEPTOR AGONISTS TO TREAT SEXUAL DYSFUNCTION
UY27124A1 (en) HISTAMINE RECEIVER ANTAGONISTS
ES2155187T3 (en) BICYCLE ANTAGONISTS OF TAQUICINAS, PREPARATION OF THESE ANTAGONISTS AND ITS USE IN PHARMACEUTICAL COMPOUNDS.
DK1177191T3 (en) Substituted benzimidazoles, preparation and use thereof as agents for the control of parasitic protozoa
EA200000197A1 (en) 2-ACYLAMINOPROPANAMINES AS ANTAGONISTS OF TACHYKININ RECEPTORS
ES2172939T3 (en) NEW COMPOUNDS THAT ARE ANTAGONISTS OF RECEPTORS COUPLED TO PROTEIN G 7-TRANSMEMBRANE (TM) P2-PURINOCEPTORS.
DK1420789T3 (en) Use of active substances with myopioid receptor agonist and opioid receptor antagonist effect as combination drugs for cancer treatment

Legal Events

Date Code Title Description
FD Lapse